Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Components

v3.23.3
Balance Sheet Components
 9 Months Ended
Sep. 30, 2023
Balance Sheet Components [Abstract]  
Balance Sheet Components

5. Balance Sheet Components

 

Prepaid expenses and other current assets as of December 31, 2022, and September 30, 2023, consisted of the following (in thousands):

 

    As of     As of  
    December 31,     September 30,  
    2022     2023  
             
Directors’ and officers’ liability insurance premiums   $ 476     $ 399  
Research and development services     1,554       3,143  
Other     159       682  
Total   $ 2,189     $ 4,224  

 

Property, plant and equipment as of December 31, 2022, and September 30, 2023, consisted of the following (in thousands):

 

    As of     As of  
    December 31,     September 30,  
    2022     2023  
             
Leasehold improvements   $      15     $ 21  
Furniture and fixtures     14       21  
Subtotal     29       42  
Less accumulated depreciation     (7 )     (14 )
Net   $ 22     $ 28  

 

Accounts payable as of December 31, 2022, and September 30, 2023, consisted of the following (in thousands):

 

    As of     As of  
    December 31,     September 30,  
    2022     2023  
             
Trade accounts payable   $     846     $ 990  
Credit card liability     46       94  
Total   $ 892     $ 1,084  

 

Accrued liabilities as of December 31, 2022, and September 30, 2023, consisted of the following (in thousands):

 

    As of     As of  
    December 31,     September 30,  
    2022     2023  
             
Accrued labor costs   $ 1,487     $ 1,358  
Accrued drug development costs     228       671  
Other     522       501  
Total   $ 2,237     $ 2,530